Skip to main content
SpringerLink
Log in

Paramyxoviruses: Parainfluenza Viruses

  • Chapter
  • First Online:
Book cover Viral Infections of Humans

Abstract

Human parainfluenza viruses (HPIVs) are a group of respiratory viruses that cause human diseases including bronchitis, croup, bronchiolitis, and pneumonia in infants, children, and immunocompromised individuals. HPIVs, in combination with influenza virus and respiratory syncytial virus, are responsible for the majority of respiratory viral infections that require medical attention. These viruses were first described in 1956; longitudinal studies of community and family HPIV disease were carried out during the twentieth century. More recently, HPIV has been recognized as an important and serious cause of pneumonia in immunocompromised patients and an important etiology of lower respiratory tract disease in people of all ages. Epidemiologic studies documenting the importance of HPIVs have been mainly conducted in developed countries, but new sensitive molecular diagnostic tools are being utilized to further characterize HPIV disease in diverse populations worldwide. In recent years, the molecular mechanisms of paramyxovirus cell entry and replication are becoming better understood. Paramyxoviruses enter the target cell by binding to a cell surface receptor and then fusing the viral envelope with the target cell membrane, allowing the release of the viral genome into the cytoplasm. Binding and fusion are driven by viral “fusion machinery” consisting of the receptor-binding protein and the fusion protein. Better understanding of these crucial steps may help advance the development of antiviral therapies. No effective HPIV therapies are currently available, but new HPIV vaccines and antivirals are currently being actively studied in children and immunocompromised individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.

    PubMed  PubMed Central  Google Scholar 

  2. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443–50.

    PubMed  CAS  PubMed Central  Google Scholar 

  3. Loughlin GM, Moscona A. The cell biology of acute childhood respiratory disease: therapeutic implications. Pediatr Clin North Am. 2006;53:929–59, ix–x.

    PubMed  Google Scholar 

  4. Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant. 2013;17:133–43.

    PubMed  CAS  Google Scholar 

  5. Roghmann M, Ball K, Erdman D, Lovchik J, Anderson LJ, Edelman R. Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant. 2003;32:1085–8.

    PubMed  CAS  Google Scholar 

  6. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effecton transplant outcome. Blood 2001;98:573–6.

    Google Scholar 

  7. Weinberg GA, Hall CB, Iwane MK, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009;154:694–9.

    PubMed  Google Scholar 

  8. Rosychuk RJ, Klassen TP, Metes D, Voaklander DC, Senthilselvan A, Rowe BH. Croup presentations to emergency departments in Alberta, Canada: a large population-based study. Pediatr Pulmonol. 2010;45:83–91.

    PubMed  Google Scholar 

  9. Park SY, Baek S, Lee SO, et al. Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores. Antimicrob Agents Chemother. 2013;57:983–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  10. Chanock RM. Association of a new type of cytopathogenic myxovirus with infantile croup. J Exp Med. 1956;104:555–76.

    PubMed  CAS  PubMed Central  Google Scholar 

  11. Chanock RM, Parrott RH, Cook K, et al. Newly recognized myxoviruses from children with respiratory disease. N Engl J Med. 1958;258:207–13.

    PubMed  CAS  Google Scholar 

  12. Andrewes CH, Bang FB, Chanock RM, Zhdanov VM. Para-influenza viruses 1, 2, and 3: suggested names for recently described myxoviruses. Virology. 1959;8:129–30.

    PubMed  CAS  Google Scholar 

  13. Johnson KM, Chanock RM, Cook MK, Huebner RJ. Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. Am J Hyg. 1960;71:81–92.

    PubMed  CAS  Google Scholar 

  14. Kuroya M, Ishida N. Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus possessing hemagglutinin activity. Yokohama Med Bull. 1953;4:217–33.

    PubMed  CAS  Google Scholar 

  15. Cook MK, Andrews BE, Fox HH, Turner HC, James WD, Chanock RM. Antigenic relationships among the newer myxoviruses (parainfluenza). Am J Hyg. 1959;69:250–64.

    PubMed  CAS  Google Scholar 

  16. Cook MK, Chanock RM. In vivo antigenic studies of parainfluenza viruses. Am J Hyg. 1963;77:150–9.

    PubMed  CAS  Google Scholar 

  17. Reisinger RC, Heddleston KL, Manthei CA. A myxovirus (SF-4) associated with shipping fever of cattle. J Am Vet Med Assoc. 1959;135:147–52.

    PubMed  CAS  Google Scholar 

  18. Abinanti FR, Chanock RM, Cook MK, Wong D, Warfield M. Relationship of human and bovine strains of myxovirus para-influenza 3. Proc Soc Exp Biol Med. 1961;106:466–9.

    PubMed  CAS  Google Scholar 

  19. Hull RN, Minner JR, Smith JW. New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents S.V.1, S.V.2, S.V.4, S.V.5, S.V.6, S.V.11, S.V.12 and S.V.15. Am J Hyg. 1956;63:204–15.

    PubMed  CAS  Google Scholar 

  20. Hsiung GD, Isacson P, Tucker G. Studies of Parainfluenza Viruses. II. Serologic Interrelationships in Humans. Yale J Biol Med. 1963;35:534–44.

    PubMed  CAS  PubMed Central  Google Scholar 

  21. Voneuler L, Kantor FS, Hsiung GD. Studies of parainfluenza viruses. I. Clinical, pathological and virological observations. Yale J Biol Med. 1963;35:523–33.

    PubMed  CAS  Google Scholar 

  22. Jackson GG, Muldoon RL. Viruses causing common respiratory infections in man. II. Enteroviruses and paramyxoviruses. J Infect Dis. 1973;128:387–469.

    PubMed  CAS  Google Scholar 

  23. Ray R, Brown VE, Compans RW. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. J Infect Dis. 1985;152:1219–30.

    PubMed  CAS  Google Scholar 

  24. Scheid A, Choppin PW. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 1977;80:54–66.

    PubMed  CAS  Google Scholar 

  25. Porotto M, Murrell M, Greengard O, Moscona A. Triggering of human parainfluenza virus 3 fusion protein(F) by the hemagglutinin-neuraminidase (HN): an HN mutation diminishing the rate of F activation and fusion. J Virol. 2003;77:3647–54.

    PubMed  CAS  PubMed Central  Google Scholar 

  26. Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115:1688–98.

    PubMed  CAS  PubMed Central  Google Scholar 

  27. Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol. 2007;81:3216–28.

    PubMed  CAS  PubMed Central  Google Scholar 

  28. Porotto M, Devito I, Palmer SG, et al. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol. 2011;85:12867–80.

    PubMed  CAS  PubMed Central  Google Scholar 

  29. Coelingh KV, Winter CC. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites. J Virol. 1990;64:1329–34.

    PubMed  CAS  PubMed Central  Google Scholar 

  30. Henrickson KJ, Savatski LL. Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: analysis of 12 clinical isolates. J Infect Dis. 1992;166:995–1005.

    PubMed  CAS  Google Scholar 

  31. Miller WS, Artenstein MS. Aerosol stability of three acute respiratory disease viruses. Proc Soc Exp Biol Med. 1967;125:222–7.

    PubMed  CAS  Google Scholar 

  32. McLean DM, Bannatyne RM, Givan KF. Myxovirus dissemination by air. Can Med Assoc J. 1967;96:1449–53.

    PubMed  CAS  PubMed Central  Google Scholar 

  33. Zhang L, Bukreyev A, Thompson CI, et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol. 2005;79:1113–24.

    PubMed  CAS  PubMed Central  Google Scholar 

  34. Chanock RM, Parrott RH. Acute respiratory disease in infancy and childhood: present understanding and prospects for prevention. Pediatrics. 1965;36:21–39.

    PubMed  CAS  Google Scholar 

  35. Gardner PS, McQuillin J, McGuckin R, Ditchburn RK. Observations on clinical and immunofluorescent diagnosis of parainfluenza virus infections. Br Med J. 1971;2:7–12.

    PubMed  CAS  PubMed Central  Google Scholar 

  36. Glezen WP, Loda FA, Clyde Jr WA, et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971;78:397–406.

    PubMed  CAS  Google Scholar 

  37. Mufson MA, Krause HE, Mocega HE, Dawson FW. Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants. Am J Epidemiol. 1970;91:192–202.

    PubMed  CAS  Google Scholar 

  38. Chanock RM, Parrott RH, Johnson KM, Kapikian AZ, Bell JA. Myxoviruses: parainfluenza. Am Rev Respir Dis. 1963;88(SUPPL):152–66.

    PubMed  Google Scholar 

  39. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981;144:433–41.

    PubMed  CAS  Google Scholar 

  40. Gross PA, Green RH, Curnen MG. Persistent infection with parainfluenza type 3 virus in man. Am Rev Respir Dis. 1973;108:894–8.

    PubMed  CAS  Google Scholar 

  41. Loda FA, Glezen WP, Clyde Jr WA. Respiratory disease in group day care. Pediatrics. 1972;49:428–37.

    PubMed  CAS  Google Scholar 

  42. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood. 2007;110:1681–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  43. Tyrrell DA, Bynoe ML, Petersen KB, Sutton RN, Pereira MS. Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). Br Med J. 1959;2:909–11.

    PubMed  CAS  PubMed Central  Google Scholar 

  44. Wong DT, Welliver RC, Riddlesberger KR, Sun MS, Ogra PL. Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol. 1982;16:164–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  45. Heidemann SM. Clinical characteristics of parainfluenza virus infection in hospitalized children. Pediatr Pulmonol. 1992;13:86–9.

    PubMed  CAS  Google Scholar 

  46. Henrickson KJ. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates. J Infect Dis. 1991;164:1128–34.

    PubMed  CAS  Google Scholar 

  47. Klippmark E, Rydbeck R, Shibuta H, Norrby E. Antigenic variation of human and bovine parainfluenza virus type 3 strains. J Gen Virol. 1990;71(Pt 7):1577–80.

    PubMed  CAS  Google Scholar 

  48. Merson JR, Hull RA, Estes MK, Kasel JA. Molecular cloning and sequence determination of the fusion protein gene of human parainfluenza virus type 1. Virology. 1988;167:97–105.

    PubMed  CAS  Google Scholar 

  49. Ray R, Duncan J, Quinn R, Matsuoka Y. Distinct hemagglutinin and neuraminidase epitopes involved in antigenic variation of recent human parainfluenza virus type 2 isolates. Virus Res. 1992;24:107–13.

    PubMed  CAS  Google Scholar 

  50. van Wyke Coelingh K, Tierney EL. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol. 1989;63:375–82.

    PubMed  PubMed Central  Google Scholar 

  51. Eugene-Ruellan G, Freymuth F, Bahloul C, Badrane H, Vabret A, Tordo N. Detection of respiratory syncytial virus A and B and parainfluenza virus 3 sequences in respiratory tracts of infants by a single PCR with primers targeted to the L-polymerase gene and differential hybridization. J Clin Microbiol. 1998;36:796–801.

    PubMed  CAS  PubMed Central  Google Scholar 

  52. Fairchok MP, Martin ET, Kuypers J, Englund JA. A prospective study of parainfluenza virus type 4 infections in children attending daycare. Pediatr Infect Dis J. 2011;30:714–6.

    PubMed  Google Scholar 

  53. Huguenin A, Moutte L, Renois F, et al. Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol. 2012;84:979–85.

    PubMed  CAS  Google Scholar 

  54. Jalal H, Bibby DF, Bennett J, et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol. 2007;45:1690–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  55. Karron RA, O’Brien KL, Froehlich JL, Brown VA. Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J Infect Dis. 1993;167:1441–5.

    PubMed  CAS  Google Scholar 

  56. Kunz AN, Englund JA, Kuypers J, Maranich A, Fairchok MP. Detection of multiple respiratory viruses by real-time polymerase chain reaction in infants attending an outpatient clinic. Eur J Clin Microbiol Infect Dis. 2008;27:1245–8.

    PubMed  CAS  Google Scholar 

  57. Kuypers J, Wright N, Ferrenberg J, et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol. 2006;44:2382–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  58. Lau SK, Li KS, Chau KY, et al. Clinical and molecular epidemiology of human parainfluenza virus 4 infections in Hong Kong: subtype 4B as common as subtype 4A. J Clin Microbiol. 2009;47:1549–52.

    PubMed  PubMed Central  Google Scholar 

  59. He B, Leser GP, Paterson RG, Lamb RA. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology. 1998;250:30–40.

    PubMed  CAS  Google Scholar 

  60. Henrickson KJ. Advances in the laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J. 2004;23:S6–10.

    PubMed  Google Scholar 

  61. Henrickson KJ. Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann. 2005;34:24–31.

    PubMed  Google Scholar 

  62. Henrickson KJ, Hoover S, Kehl KS, Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004;23:S11–8.

    PubMed  Google Scholar 

  63. Puppe W, Weigl JA, Aron G, et al. Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. J Clin Virol. 2004;30:165–74.

    PubMed  CAS  Google Scholar 

  64. Krunic N, Merante F, Yaghoubian S, Himsworth D, Janeczko R. Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel. Ann N Y Acad Sci. 2011;1222:6–13.

    PubMed  Google Scholar 

  65. Simoes EA, Patel C, Sung WK, et al. A pathogen chip for respiratory tract infections. J Clin Microbiol. 2013;51:945–53.

    PubMed  CAS  PubMed Central  Google Scholar 

  66. Raymaekers M, de Rijke B, Pauli I, Van den Abeele AM, Cartuyvels R. Timely diagnosis of respiratory tract infections: evaluation of the performance of the Respifinder assay compared to the xTAG respiratory viral panel assay. J Clin Virol. 2011;52:314–6.

    PubMed  CAS  Google Scholar 

  67. Schulert GS, Lu Z, Wingo T, Tang YW, Saville BR, Hain PD. Role of a respiratory viral panel in the clinical management of pediatric inpatients. Pediatr Infect Dis J. 2013;35:467–72.

    Google Scholar 

  68. Selvaraju SB, Selvarangan R. Evaluation of xTAG Respiratory Viral Panel FAST and xTAG Human Parainfluenza Virus Analyte-Specific Reagents for detection of human parainfluenza viruses in respiratory specimens. Diagn Microbiol Infect Dis. 2012;72:278–81.

    PubMed  CAS  Google Scholar 

  69. Babady NE, Mead P, Stiles J, et al. Comparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol. 2012;50:2282–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  70. Kehl SC, Henrickson KJ, Hua W, Fan J. Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol. 2001;39:1696–701.

    PubMed  CAS  PubMed Central  Google Scholar 

  71. Xu M, Qin X, Astion ML, et al. Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol. 2013;139:118–23.

    PubMed  Google Scholar 

  72. Briese T, Palacios G, Kokoris M, et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis. 2005;11:310–3.

    PubMed  PubMed Central  Google Scholar 

  73. Julkunen I. Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens. J Med Virol. 1984;14:177–87.

    PubMed  CAS  Google Scholar 

  74. Karron RA, Wright PF, Belshe RB, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis. 2005;191:1093–104.

    PubMed  Google Scholar 

  75. Brown PK, Taylor-Robinson D. Respiratory virus antibodies in sera of persons living in isolated communities. Bull World Health Organ. 1966;34:895–900.

    PubMed  CAS  PubMed Central  Google Scholar 

  76. Hornsleth A. Respiratory virus disease in infancy and childhood in Copenhagen 1963–65. An estimation of the etiology based on complement fixation tests. Acta Pathol Microbiol Scand. 1967;69:287–303.

    Google Scholar 

  77. La Placa M, Moscovici C. Distribution of parainfluenza antibodies in different groups of population. J Immunol. 1962;88:72–7.

    Google Scholar 

  78. Ma CC, Tai FH. Antibody patterns of parainfluenza viruses in human populations on Taiwan. Am Rev Respir Dis. 1968;97:941–5.

    PubMed  CAS  Google Scholar 

  79. Monozenko MA, Banysheva AE, Temofeyeva GA, Bystoyakava LV, Kalinnikova ON. Diagnostic value of the complement fixation reaction in viral respiratory infections of infants. Acta Virol. 1963;7:534–41.

    Google Scholar 

  80. Monto AS, Johnson KM. Respiratory infections in the American tropics. Am J Trop Med Hyg. 1968;17:867–74.

    PubMed  CAS  Google Scholar 

  81. Evans AS, Dick EC. Acute pharyngitis and tonsillitis in University of Wisconsin Students. JAMA. 1964;190:699–708.

    PubMed  CAS  Google Scholar 

  82. Foy HM, Cooney MK, Maletzky AJ, Grayston JT. Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol. 1973;97:80–92.

    PubMed  CAS  Google Scholar 

  83. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499–505.

    PubMed  CAS  Google Scholar 

  84. Hall CE, Brandt CD, Frothingham TE, Spigland I, Cooney MK, Fox JP. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. IX. A comparison of infections with several respiratory pathogens in New York and New Orleans families. Am J Epidemiol. 1971;94:367–85.

    PubMed  CAS  Google Scholar 

  85. Mogabgab WJ. Acute respiratory illnesses in university (1962-1966), military and industrial (1962-1963) populations. Am Rev Respir Dis. 1968;98:359–79.

    PubMed  CAS  Google Scholar 

  86. Monto AS. The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenza viruses. Am J Epidemiol. 1973;97:338–48.

    PubMed  CAS  Google Scholar 

  87. Brandt CD, Kim HW, Chanock RM, Parrott RS. Parainfluenza virus epidemiology. Pediatr Res. 1974;8:422.

    Google Scholar 

  88. Denny FW, Clyde Jr WA. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr. 1986;108:635–46.

    PubMed  CAS  Google Scholar 

  89. Glezen P, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973;288:498–505.

    PubMed  CAS  Google Scholar 

  90. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110:145–60.

    PubMed  CAS  PubMed Central  Google Scholar 

  91. Gardner G, Frank AL, Taber LH. Effects of social and family factors on viral respiratory infection and illness in the first year of life. J Epidemiol Community Health. 1984;38:42–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  92. Glezen WP, Frank AL, Taber LH, Kasel JA. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis. 1984;150:851–7.

    PubMed  CAS  Google Scholar 

  93. Taussig LM, Wright AL, Morgan WJ, Harrison HR, Ray CG. The Tucson Children’s Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. Am J Epidemiol. 1989;129:1219–31.

    PubMed  CAS  Google Scholar 

  94. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children’s Respiratory Study. II. Lower respiratory tract illness in the first year of life. Am J Epidemiol. 1989;129:1232–46.

    PubMed  CAS  Google Scholar 

  95. Clarke SK. Parainfluenza virus infections. Postgrad Med J. 1973;49:792–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  96. Martin AJ, Gardner PS, McQuillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in north-east England. Lancet. 1978;2:1035–8.

    PubMed  CAS  Google Scholar 

  97. Herrmann Jr EC, Hable KA. Experiences in laboratory diagnosis of parainfluenza viruses in routine medical practice. Mayo Clin Proc. 1970;45:177–88.

    PubMed  Google Scholar 

  98. Holzel A, Parker L, Patterson WH, et al. Virus isolations from throats of children admitted to hospital with respiratory and other diseases, Manchester 1962-4. Br Med J. 1965;1:614–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  99. Horstmann DM, Hsiung GD. Myxovirus infections and respiratory illnesses in children. Clin Pediatr (Phila). 1963;2:378–86.

    CAS  Google Scholar 

  100. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113:1758–64.

    PubMed  Google Scholar 

  101. McLean DM, Bach RD, Larke RP, McNaughton GA. Myxoviruses associated with acute laryngotracheobronchitis in Toronto, 1962-63. Can Med Assoc J. 1963;89:1257–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  102. Pereira MS, Fisher OD. An outbreak of acute laryngotracheobronchitis associated with parainfluenza-2 virus. Lancet. 1960;2:790–1.

    PubMed  CAS  Google Scholar 

  103. Vargosko AJ, Chanock RM, Huebner RJ, et al. Association of type 2 hemadsorption (parainfluenza 1) virus and Asian influenza A virus with infections croup. N Engl J Med. 1959;261:1–9.

    PubMed  CAS  Google Scholar 

  104. Zollar LM, Krause HE, Mufson MA. Microbiologic studies on young infants with lower respiratory tract disease. Am J Dis Child. 1973;126:56–60.

    PubMed  CAS  Google Scholar 

  105. Herzog KD, Dunn SP, Langham Jr MR, Marmon LM. Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient. Pediatr Infect Dis J. 1989;8:534–6.

    PubMed  CAS  Google Scholar 

  106. Wendt C, Weisdorf D, Jordan M, Balfour H, Hertz M. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med. 1992;326:921–6.

    PubMed  CAS  Google Scholar 

  107. Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186:325–32.

    PubMed  Google Scholar 

  108. Aitken CJ, Moffat MA, Sutherland JA. Respiratory illness and viral infection in an Edinburgh nursery. J Hyg (Lond). 1967;65:25–36.

    CAS  Google Scholar 

  109. Harris DJ, Wulff H, Ray CG, Poland JD, Chin TD, Wenner HA. Viruses and disease. II. An outbreak of parainfluenza Type 2 in a children’s home. Am J Epidemiol. 1968;87:419–25.

    PubMed  CAS  Google Scholar 

  110. Kapikian AZ, Bell JA, Mastrota FM, Huebner RJ, Wong DC, Chanock RM. An outbreak of parainfluenza 2 (croup-associated) virus infection. Association with acute undifferentiated febrile illness in children. JAMA. 1963;183:324–30.

    PubMed  CAS  Google Scholar 

  111. Fairchok MP, Martin ET, Chambers S, et al. Epidemiology of viral respiratory tract infections in a prospective cohort of infants and toddlers attending daycare. J Clin Virol. 2010;49:16–20.

    PubMed  Google Scholar 

  112. Saliba GS, Glezen WP, Chin TD. Etiologic studies of acute respiratory illness among children attending public schools. Am Rev Respir Dis. 1967;95:592–602.

    PubMed  CAS  Google Scholar 

  113. Glezen WP, Wulff H, Lamb GA, Ray CG, Chin TD, Wenner HA. Patterns of virus infections in families with acute respiratory illnesses. Am J Epidemiol. 1967;86:350–61.

    PubMed  CAS  Google Scholar 

  114. Hope-Simpson RE, Higgins PG. A respiratory virus study in Great Britain: review and evaluation. Prog Med Virol. 1969;11:354–407.

    PubMed  CAS  Google Scholar 

  115. Lambert SB, Allen KM, Druce JD, et al. Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens. Pediatrics. 2007;120:e929–37.

    PubMed  Google Scholar 

  116. Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr. 2009;98:123–6.

    PubMed  PubMed Central  Google Scholar 

  117. Busse WW, Lemanske Jr RF, Dick EC. The relationship of viral respiratory infections and asthma. Chest. 1992;101:385S–8.

    PubMed  CAS  Google Scholar 

  118. McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, Fulginiti VA. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr. 1973;82:578–90.

    PubMed  CAS  Google Scholar 

  119. Singh-Naz N, Willy M, Riggs N. Outbreak of parainfluenza virus type 3 in a neonatal nursery. Pediatr Infect Dis J. 1990;9:31–3.

    PubMed  CAS  Google Scholar 

  120. Srinivasan A, Wang C, Yang J, Shenep JL, Leung WH, Hayden RT. Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1520–7.

    PubMed  Google Scholar 

  121. Nichols W, Corey L, Gooley T, Davis C. Boeckh. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98:573–8.

    PubMed  CAS  Google Scholar 

  122. Sparrelid E, Ljungman P, Ekelof-Andstrom E, et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant. 1997;19:905–8.

    PubMed  CAS  Google Scholar 

  123. Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis. 2001;32:413–8.

    PubMed  CAS  Google Scholar 

  124. Evans AS. Infections with hemadsorption virus in University of Wisconsin students. N Engl J Med. 1960;263:233–7.

    PubMed  CAS  Google Scholar 

  125. Gwaltney Jr JM, Hendley JO, Simon G, Jordan Jr WS. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966;275:1261–8.

    PubMed  Google Scholar 

  126. Hamre D, Connelly Jr AP, Procknow JJ. Virologic studies of acute respiratory disease in young adults. IV. Virus isolations during four years of surveillance. Am J Epidemiol. 1966;83:238–49.

    PubMed  CAS  Google Scholar 

  127. Mufson MA, Chang V, Gill V, Wood SC, Romansky MJ, Chanock RM. The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol. 1967;86:526–44.

    PubMed  CAS  Google Scholar 

  128. Sullivan Jr RJ, Dowdle WR, Marine WM, Hierholzer JC. Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med. 1972;129:935–42.

    PubMed  Google Scholar 

  129. Wenzel RP, McCormick DP, Beam Jr WE. Parainfluenza pneumonia in adults. JAMA. 1972;221:294–5.

    PubMed  CAS  Google Scholar 

  130. Falsey AR, Dallal GE, Formica MA, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc. 2008;56:1281–5.

    PubMed  PubMed Central  Google Scholar 

  131. Glezen WP, Couch RB. Estimating deaths due to influenza and respiratory syncytial virus. JAMA. 2003;289:2500; author reply 2500–2.

    PubMed  Google Scholar 

  132. Kapikian AZ, Chanock RM, Reichelderfer TE, Ward TG, Huebner RJ, Bell JA. Inoculation of human volunteers with parainfluenza virus type 3. JAMA. 1961;178:537–41.

    PubMed  CAS  Google Scholar 

  133. Reichelderfer TE, Chanock RM, Craighead JE, et al. Infection of human volunteers with type 2 hemadsorption virus. Science. 1958;128:779–80.

    PubMed  CAS  Google Scholar 

  134. Smith CB, Purcell RH, Bellanti JA, Chanock RM. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med. 1966;275:1145–52.

    PubMed  CAS  Google Scholar 

  135. Tremonti LP, Lin JS, Jackson GG. Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol. 1968;101:572–7.

    PubMed  CAS  Google Scholar 

  136. Taylor-Robinson D, Bynoe ML. Para-influenza 2 virus infections in adult volunteers. J Hyg (Lond). 1963;61:407–17.

    CAS  Google Scholar 

  137. Vihma L. Surveillance of acute viral respiratory diseases in children. Acta Paediatr Scand Suppl. 1969;192:1–52.

    PubMed  CAS  Google Scholar 

  138. Bisno AL, Barratt NP, Swanston WH, Spence LP. An outbreak of acute respiratory disease in Trinidad associated with para-influenza viruses. Am J Epidemiol. 1970;91:68–77.

    PubMed  CAS  Google Scholar 

  139. Kloene W, Bang FB, Chakraborty SM, et al. A two-year respiratory virus survey in four villages in West Bengal, India. Am J Epidemiol. 1970;92:307–20.

    PubMed  CAS  Google Scholar 

  140. Olson LC, Lexomboon U, Sithisarn P, Noyes HE. The etiology of respiratory tract infections in a tropical country. Am J Epidemiol. 1973;97:34–43.

    PubMed  CAS  Google Scholar 

  141. Maynard JE, Feltz ET, Wulff H, Fortuine R, Poland JD, Chin TD. Surveillance of respiratory virus infections among Alaskan Eskimo children. JAMA. 1967;200:927–31.

    PubMed  CAS  Google Scholar 

  142. Black FL, Hierholzer WJ, Pinheiro F, et al. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol. 1974;100:230–50.

    PubMed  CAS  Google Scholar 

  143. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991;13 Suppl 6:S454–62.

    PubMed  Google Scholar 

  144. Chanock R, Chambon L, Chang W, et al. WHO respiratory disease survey in children: a serological study. Bull World Health Organ. 1967;37:363–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  145. John TJ, Cherian T, Steinhoff MC, Simoes EA, John M. Etiology of acute respiratory infections in children in tropical southern India. Rev Infect Dis. 1991;13 Suppl 6:S463–9.

    PubMed  Google Scholar 

  146. Joosting AC, Harwin RM, Orchard M, Martin E, Gear JH. Respiratory viruses in hospital patients on the Witwatersrand. A 7-year study. S Afr Med J. 1979;55:403–8.

    PubMed  CAS  Google Scholar 

  147. Mathisen M, Strand TA, Sharma BN, et al. RNA viruses in community-acquired childhood pneumonia in semi-urban Nepal; a cross-sectional study. BMC Med. 2009;7:35.

    PubMed  PubMed Central  Google Scholar 

  148. Ruutu P, Halonen P, Meurman O, et al. Viral lower respiratory tract infections in Filipino children. J Infect Dis. 1990;161:175–9.

    PubMed  CAS  Google Scholar 

  149. Suwanjutha S, Chantarojanasiri T, Watthana-Kasetr S, et al. A study of nonbacterial agents of acute lower respiratory tract infection in Thai children. Rev Infect Dis. 1990;12 Suppl 8:S923–8.

    PubMed  Google Scholar 

  150. Tukei P, Wafula E, Nsanze H, et al. Acute respiratory diseases among children of the world: opportunities for study in east Africa. Pediatr Res. 1983;17:1060–2.

    Google Scholar 

  151. Hughes JR, Sinha DP, Cooper MR, Shah KV, Bose SK. Lung tap in childhood. Bacteria, viruses, and mycoplasmas in acute lower respiratory tract infections. Pediatrics. 1969;44:477–85.

    PubMed  CAS  Google Scholar 

  152. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23:7–18.

    PubMed  CAS  PubMed Central  Google Scholar 

  153. Downham MA, McQuillin J, Gardner PS. Diagnosis and clinical significance of parainfluenza virus infections in children. Arch Dis Child. 1974;49:8–15.

    PubMed  CAS  PubMed Central  Google Scholar 

  154. Zinserling A. Pecularities of lesions in viral and mycoplasma infections of the respiratory tract. Virchows Arch A Pathol Pathol Anat. 1972;356:259–73.

    PubMed  CAS  Google Scholar 

  155. Delage G, Brochu P, Pelletier M, Jasmin G, Lapointe N. Giant-cell pneumonia caused by parainfluenza virus. J Pediatr. 1979;94:426–9.

    PubMed  CAS  Google Scholar 

  156. Frank Jr JA, Warren RW, Tucker JA, Zeller J, Wilfert CM. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am J Dis Child. 1983;137:1172–4.

    PubMed  Google Scholar 

  157. Jarvis WR, Middleton PJ, Gelfand EW. Parainfluenza pneumonia in severe combined immunodeficiency disease. J Pediatr. 1979;94:423–5.

    PubMed  CAS  Google Scholar 

  158. Berman S, McIntosh K. Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis. 1985;7:674–91.

    PubMed  CAS  Google Scholar 

  159. Feikin DR, Njenga MK, Bigogo G, et al. Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS One. 2012;7:e43656.

    PubMed  CAS  PubMed Central  Google Scholar 

  160. Ghani AS, Morrow BM, Hardie DR, Argent AC. An investigation into the prevalence and outcome of patients admitted to a pediatric intensive care unit with viral respiratory tract infections in Cape Town, South Africa. Pediatr Crit Care Med. 2012;13:e275–81.

    PubMed  Google Scholar 

  161. Parrott RH, Vargosko AJ, Kim HW, Bell JA, Chanock RM. Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses. Am J Public Health Nations Health. 1962;52:907–17.

    PubMed  CAS  PubMed Central  Google Scholar 

  162. Tyrrell DA, Peto M, King N. Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond). 1967;65:327–41.

    CAS  Google Scholar 

  163. Mufson MA, Mocega HE, Krause HE. Acquisition of parainfluenza 3 virus infection by hospitalized children. I. Frequencies, rates, and temporal data. J Infect Dis. 1973;128:141–7.

    PubMed  CAS  Google Scholar 

  164. Gardner SD. The isolation of parainfluenza 4 subtypes A and B in England and serological studies of their prevalence. J Hyg (Lond). 1969;67:545–50.

    CAS  Google Scholar 

  165. Killgore GE, Dowdle WR. Antigenic characterization of parainfluenza 4A and 4B by the hemagglutination-inhibition test and distribution of HI antibody in human sera. Am J Epidemiol. 1970;91:308–16.

    PubMed  CAS  Google Scholar 

  166. Tyrrell DA, Bynoe ML. Studies on parainfluenza type 2 and 4 viruses obtained from patients with common colds. Br Med J. 1969;1:471–4.

    PubMed  CAS  PubMed Central  Google Scholar 

  167. Vachon ML, Dionne N, Leblanc E, Moisan D, Bergeron MG, Boivin G. Human parainfluenza type 4 infections, Canada. Emerg Infect Dis. 2006;12:1755–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  168. Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis. 2006;43:1016–22.

    PubMed  Google Scholar 

  169. Denny FW, Murphy TF, Clyde Jr WA, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71:871–6.

    PubMed  CAS  Google Scholar 

  170. Kim HW, Vargosko AJ, Chanock RM, Parrott RH. Para-influenza 2 (CA) virus: etiologic association with croup. Pediatrics. 1961;28:614–21.

    PubMed  CAS  Google Scholar 

  171. Billaud G, Morfin F, Vabret A, et al. Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002. J Clin Virol. 2005;34:48–51.

    PubMed  Google Scholar 

  172. Lindquist SW, Darnule A, Istas A, Demmler GJ. Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J. 1997;16:34–8.

    PubMed  CAS  Google Scholar 

  173. Doraisingham S, Ling AE. Acute non-bacterial infections of the respiratory tract in Singapore children: an analysis of three years’ laboratory findings. Ann Acad Med Singapore. 1981;10:69–78.

    PubMed  CAS  Google Scholar 

  174. Singleton RJ, Bulkow LR, Miernyk K, et al. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol. 2010;82:1282–90.

    PubMed  Google Scholar 

  175. Ng W, Rajadurai VS, Pradeepkumar VK, Tan KW, Chan KP. Parainfluenza type 3 viral outbreak in a neonatal nursery. Ann Acad Med Singapore. 1999;28:471–5.

    PubMed  CAS  Google Scholar 

  176. Teo WY, Rajadurai VS, Sriram B. Morbidity of parainfluenza 3 outbreak in preterm infants in a neonatal unit. Ann Acad Med Singapore. 2010;39:837–6.

    PubMed  Google Scholar 

  177. Marx A, Gary Jr HE, Marston BJ, et al. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis. 1999;29:134–40.

    PubMed  CAS  Google Scholar 

  178. Banatvala JE, Anderson TB, Reiss BB. Parainfluenza infections in the community. Br Med J. 1964;1:537–40.

    PubMed  CAS  PubMed Central  Google Scholar 

  179. Yamakoshi M, Suzuki K, Yamamoto T, et al. An outbreak of parainfluenza 3 virus infection in the elderly in a ward. Kansenshogaku Zasshi. 1999;73:298–304.

    PubMed  CAS  Google Scholar 

  180. Yamakoshi M, Suzuki K, Nakakita T, Goto N, Nakamura A, Yamada Y. Respiratory viral infections in the elderly in a nursing home. Kansenshogaku Zasshi. 1998;72:876–82.

    PubMed  CAS  Google Scholar 

  181. Glasgow KW, Tamblyn SE, Blair G. A respiratory outbreak due to parainfluenza virus type 3 in a home for the aged–Ontario. Can Commun Dis Rep. 1995;21:57–61.

    PubMed  CAS  Google Scholar 

  182. Rabe EF. Infectious croup; virus croup. Pediatrics. 1948;2:415–27.

    PubMed  CAS  Google Scholar 

  183. Maletzky AJ, Cooney MK, Luce R, Kenny GE, Grayston JT. Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population. J Pediatr. 1971;78:407–14.

    PubMed  CAS  Google Scholar 

  184. Gardner PS, Court SD, Brocklebank JT, Downham MA, Weightman D. Virus cross-infection in paediatric wards. Br Med J. 1973;2:571–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  185. Sims DG. A two year prospective study of hospital-acquired respiratory virus infection on paediatric wards. J Hyg (Lond). 1981;86:335–42.

    CAS  Google Scholar 

  186. Welliver RC, Kaul TN, Sun M, Ogra PL. Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol. 1984;133:1925–30.

    PubMed  CAS  Google Scholar 

  187. Meissner HC, Murray SA, Kiernan MA, Snydman DR, McIntosh K. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr. 1984;104:680–4.

    PubMed  CAS  Google Scholar 

  188. Josephs S, Kim HW, Brandt CD, Parrott RH. Parainfluenza 3 virus and other common respiratory pathogens in children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1988;7:207–9.

    PubMed  CAS  Google Scholar 

  189. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine. 2006;85:278–87.

    PubMed  Google Scholar 

  190. Ustun C, Slaby J, Shanley RM, et al. Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time. Biol Blood Marrow Transplant. 2012;18:1580–8.

    PubMed  PubMed Central  Google Scholar 

  191. Zambon M, Bull T, Sadler CJ, Goldman JM, Ward KN. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol. 1998;36:2289–93.

    PubMed  CAS  PubMed Central  Google Scholar 

  192. DeLaMora P, Moscona A. A daring treatment and a successful outcome: the need for targeted therapies for pediatric respiratory viruses. Pediatr Transplant. 2007;11:121–3.

    PubMed  Google Scholar 

  193. Campbell AP, Chien JW, Kuypers J, et al. Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. J Infect Dis. 2010;201:1404–13.

    PubMed  PubMed Central  Google Scholar 

  194. Vilchez RA, McCurry K, Dauber J, et al. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis. 2001;33:2004–8.

    PubMed  CAS  Google Scholar 

  195. Muchmore HG, Parkinson AJ, Humphries JE, et al. Persistent parainfluenza virus shedding during isolation at the South Pole. Nature. 1981;289:187–9.

    PubMed  CAS  Google Scholar 

  196. Parkinson AJ, Muchmore HG, McConnell TA, Scott LV, Miles JA. Serologic evidence for parainfluenza virus infection during isolation at South Pole Station, Antarctica. Am J Epidemiol. 1980;112:334–40.

    PubMed  CAS  Google Scholar 

  197. Welliver RC, Wong DT, Middleton Jr E, Sun M, McCarthy N, Ogra PL. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr. 1982;101:889–96.

    PubMed  CAS  Google Scholar 

  198. Rosner SF. Bovine parainfluenza Type 3 virus infection and pasteurellosis. J Am Vet Med Assoc. 1971;159:1375–82.

    PubMed  CAS  Google Scholar 

  199. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol. 1996;12:627–61.

    PubMed  CAS  Google Scholar 

  200. Moscona A, Peluso RW. Relative affinity of the human parainfluenza virus 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol. 1993;67:6463–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  201. Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. Influence of the human parainfluenza virus 3 attachment protein’s neuraminidase activity on its capacity to activate the fusion protein. J Virol. 2005;79:2383–92.

    PubMed  CAS  PubMed Central  Google Scholar 

  202. Moscona A, Peluso RW. Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion. J Virol. 1991;65:2773–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  203. Palermo LM, Porotto M, Greengard O, Moscona A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J Virol. 2007;81:9152–61.

    PubMed  CAS  PubMed Central  Google Scholar 

  204. Porotto M, Salah ZW, Gui L, et al. Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state. J Virol. 2012;86:12838–48.

    PubMed  CAS  PubMed Central  Google Scholar 

  205. Horvath CM. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem. 2004;271:4621–8.

    PubMed  CAS  Google Scholar 

  206. Ali A, Nayak DP. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology. 2000;276:289–303.

    PubMed  CAS  Google Scholar 

  207. Coronel EC, Murti KG, Takimoto T, Portner A. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol. 1999;73:7035–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  208. Coronel EC, Takimoto T, Murti KG, Varich N, Portner A. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol. 2001;75:1117–23.

    PubMed  CAS  PubMed Central  Google Scholar 

  209. Mottet G, Muhlemann A, Tapparel C, Hoffmann F, Roux L. A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding. Virology. 1996;221:159–71.

    PubMed  CAS  Google Scholar 

  210. Mottet G, Muller V, Roux L. Characterization of Sendai virus M protein mutants that can partially interfere with virus particle production. J Gen Virol. 1999;80(Pt 11):2977–86.

    PubMed  CAS  Google Scholar 

  211. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. Role of matrix and fusion proteins in budding of Sendai virus. J Virol. 2001;75:11384–91.

    PubMed  CAS  PubMed Central  Google Scholar 

  212. Bose S, Malur A, Banerjee AK. Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol. 2001;75:1984–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  213. De BP, Banerjee AK. Involvement of actin microfilaments in the transcription/replication of human parainfluenza virus type 3: possible role of actin in other viruses. Microsc Res Tech. 1999;47:114–23.

    PubMed  CAS  Google Scholar 

  214. Gupta S, De BP, Drazba JA, Banerjee AK. Involvement of actin microfilaments in the replication of human parainfluenza virus type 3. J Virol. 1998;72:2655–62.

    PubMed  CAS  PubMed Central  Google Scholar 

  215. Pastey MK, Crowe JE, Graham BS. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J Virol. 1999;73:7262–70.

    PubMed  CAS  PubMed Central  Google Scholar 

  216. Pastey MK, Gower TL, Spearman PW, Crowe Jr JE, Graham BS. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med. 2000;6:35–40.

    PubMed  CAS  Google Scholar 

  217. Tashiro M, Seto JT, Klenk HD, Rott R. Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells. J Virol. 1993;67:5902–10.

    PubMed  CAS  PubMed Central  Google Scholar 

  218. Katze MG, He Y, Gale Jr M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675–87.

    PubMed  CAS  Google Scholar 

  219. He B, Paterson RG, Stock N, et al. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology. 2002;303:15–32.

    PubMed  CAS  Google Scholar 

  220. Wansley EK, Parks GD. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J Virol. 2002;76:10109–21.

    PubMed  CAS  PubMed Central  Google Scholar 

  221. Lin GY, Lamb RA. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J Virol. 2000;74:9152–66.

    PubMed  CAS  PubMed Central  Google Scholar 

  222. Poole E, He B, Lamb RA, Randall RE, Goodbourn S. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology. 2002;303:33–46.

    PubMed  CAS  Google Scholar 

  223. Andrejeva J, Young DF, Goodbourn S, Randall RE. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol. 2002;76:2159–67.

    PubMed  CAS  PubMed Central  Google Scholar 

  224. Parisien JP, Lau JF, Rodriguez JJ, et al. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology. 2001;283:230–9.

    PubMed  CAS  Google Scholar 

  225. Nishio M, Garcin D, Simonet V, Kolakofsky D. The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif. Virology. 2002;300:92–9.

    PubMed  CAS  Google Scholar 

  226. Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol. 2003;77:6385–93.

    PubMed  CAS  PubMed Central  Google Scholar 

  227. Kubota T, Yokosawa N, Yokota S, Fujii N. Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol. 2002;76:12676–82.

    PubMed  CAS  PubMed Central  Google Scholar 

  228. Collins P, Chanock R, McIntosh K. Parainfluenza viruses. In: Fields B, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1996. p. 1205–41.

    Google Scholar 

  229. Downham M, Gardner P, McQuillin J, Ferris J. Role of respiratory viruses in childhood mortality. Br Med J. 1975;1:235–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  230. Schmidt AC, Schaap-Nutt A, Bartlett EJ, et al. Progress in the development of human parainfluenza virus vaccines. Expert Rev Respir Med. 2011;5:515–26.

    PubMed  PubMed Central  Google Scholar 

  231. Berman S, Duenas A, Bedoya A, et al. Acute lower respiratory tract illnesses in Cali, Colombia: a two-year ambulatory study. Pediatrics. 1983;71:210–8.

    PubMed  CAS  Google Scholar 

  232. Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992;120:856–62.

    PubMed  CAS  Google Scholar 

  233. Donnelly BW, McMillan JA, Weiner LB. Bacterial tracheitis: report of eight new cases and review. Rev Infect Dis. 1990;12:729–35.

    PubMed  CAS  Google Scholar 

  234. Alymova IV, Portner A, Takimoto T, Boyd KL, Babu YS, McCullers JA. The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 2005;49:398–405.

    PubMed  CAS  PubMed Central  Google Scholar 

  235. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23:S87–97.

    PubMed  Google Scholar 

  236. Stockmann C, Ampofo K, Hersh AL, et al. Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J. 2013;32:317–9.

    Google Scholar 

  237. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46:815–23.

    PubMed  PubMed Central  Google Scholar 

  238. Jones EE, Alford PL, Reingold AL, Russell H, Keeling ME, Broome CV. Predisposition to invasive pneumococcal illness following parainfluenza type 3 virus infection in chimpanzees. J Am Vet Med Assoc. 1984;185:1351–3.

    PubMed  CAS  Google Scholar 

  239. Karp D, Willis J, Wilfert CM. Parainfluenza virus II and the immunocompromised host. Am J Dis Child. 1974;127:592–3.

    PubMed  CAS  Google Scholar 

  240. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003;16:242–64.

    PubMed  CAS  PubMed Central  Google Scholar 

  241. DeFabritus AM, Riggio RR, David DS, Senterfit LB, Cheigh JS, Stenzel KH. Parainfluenza type 3 in a transplant unit. JAMA. 1979;241:384–6.

    PubMed  CAS  Google Scholar 

  242. Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant. 1995;14:479–85.

    PubMed  CAS  Google Scholar 

  243. Lewis VA, Champlin R, Englund J, et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis. 1996;23:1033–7.

    PubMed  CAS  Google Scholar 

  244. Moss RB, Steigbigel RT, Sanders RL, Fang F. Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients. Adv Virol. 2011;2011:910930.

    PubMed  PubMed Central  Google Scholar 

  245. Lange T, Franke G, Niederwieser D. Parotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantation. Leuk Lymphoma. 2006;47:1714–5.

    PubMed  Google Scholar 

  246. Erard V, Chien JW, Kim HW, et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis. 2006;193:1619–25.

    PubMed  Google Scholar 

  247. Chin J, Magoffin R, Shearer L, Schieble J, Lennette E. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969;89:449–63.

    PubMed  CAS  Google Scholar 

  248. Fulginiti V, Eller J, Sieber O, Joyner J, Minamitani M. G M. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969;89:435–48.

    PubMed  CAS  Google Scholar 

  249. Bernstein DI, Falloon J, Yi T. A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants. Vaccine. 2011;29:7042–8.

    PubMed  CAS  Google Scholar 

  250. Karron RA, Belshe RB, Wright PF, et al. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Pediatr Infect Dis J. 2003;22:394–405.

    PubMed  Google Scholar 

  251. Karron RA, Makhene M, Gay K, Wilson MH, Clements ML, Murphy BR. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr Infect Dis J. 1996;15:650–4.

    PubMed  CAS  Google Scholar 

  252. Karron RA, Thumar B, Schappell E, et al. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children. Vaccine. 2012;30:3975–81.

    PubMed  PubMed Central  Google Scholar 

  253. Madhi SA, Cutland C, Zhu Y, et al. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006;24:2432–9.

    PubMed  CAS  Google Scholar 

  254. Belshe RB, Newman FK, Anderson EL, et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis. 2004;190:2096–103.

    PubMed  Google Scholar 

  255. Belshe RB, Newman FK, Tsai TF, et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. J Infect Dis. 2004;189:462–70.

    PubMed  Google Scholar 

  256. Greenberg DP, Walker RE, Lee MS, et al. A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. J Infect Dis. 2005;191:1116–22.

    PubMed  Google Scholar 

  257. Englund JA, Karron RA, Cunningham CK, et al. Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. Vaccine 2013;31:5706–12.

    Google Scholar 

  258. Bernstein DI, Malkin E, Abughali N, Falloon J, Yi T, Dubovsky F. Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children. Pediatr Infect Dis J. 2012;31:109–14.

    PubMed  Google Scholar 

  259. Tang RS, Spaete RR, Thompson MW, et al. Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults. Vaccine. 2008;26:6373–82.

    PubMed  CAS  Google Scholar 

  260. Gomez M, Mufson MA, Dubovsky F, Knightly C, Zeng W, Losonsky G. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children. Pediatr Infect Dis J. 2009;28:655–8.

    PubMed  Google Scholar 

  261. Ausejo M, Saenz A, Pham B, et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ. 1999;319:595–600.

    PubMed  CAS  PubMed Central  Google Scholar 

  262. Bjornson CL, Klassen TP, Williamson J, et al. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med. 2004;351:1306–13.

    PubMed  CAS  Google Scholar 

  263. Hodson A, Kasliwal M, Streetly M, MacMahon E, Raj K. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality. Bone Marrow Transplant. 2011;46:1545–50.

    PubMed  CAS  Google Scholar 

  264. Maziarz RT, Sridharan P, Slater S, et al. Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2010;16:192–8.

    PubMed  Google Scholar 

  265. Stankova J, Carret AS, Moore D, et al. Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatr Transplant. 2007;11:209–13.

    PubMed  Google Scholar 

  266. Krilov LR. Respiratory syncytial virus disease: update on treatment and prevention. Expert Rev Anti Infect Ther. 2011;9:27–32.

    PubMed  Google Scholar 

  267. Falsey AR. Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect Drug Resist. 2012;5:121–7.

    PubMed  PubMed Central  Google Scholar 

  268. Moscona A, Porotto M, Palmer S, et al. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. J Infect Dis. 2010;202:234–41.

    PubMed  CAS  PubMed Central  Google Scholar 

  269. Triana-Baltzer GB, Sanders RL, Hedlund M, et al. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. J Antimicrob Chemother. 2011;66:15–28.

    PubMed  CAS  PubMed Central  Google Scholar 

  270. Chen YB, Driscoll JP, McAfee SL, et al. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Clin Infect Dis. 2011;53:e77–80.

    PubMed  Google Scholar 

  271. Waghmare A, Wagner T, Andrews R, Smith S, Kuypers J, Moss R, Englund JA. Successful treatment of parainfluenza virus respiratory tract infection with DAS181 in four immunocompromised children. J Pediatr Inf Dis Soc 2014;3 (in press).

    Google Scholar 

  272. Guzman-Suarez BB, Buckley MW, Gilmore ET, et al. Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients. Transpl Infect Dis. 2012;14:427–33.

    PubMed  CAS  Google Scholar 

  273. Drozd DR, Limaye AP, Moss RB, et al. DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient. Transpl Infect Dis. 2013;15:E28–32.

    PubMed  CAS  Google Scholar 

  274. Murrell M, Porotto M, Weber T, Greengard O, Moscona A. Mutations in human parainfluenza virus type 3 HN causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir). J Virol. 2003;77:309–17.

    PubMed  CAS  PubMed Central  Google Scholar 

  275. Porotto M, Greengard O, Poltoratskaia N, Horga M-A, Moscona A. Human parainfluenza virus type 3 HN-receptor interaction: the effect of 4-GU-DANA on a neuraminidase-deficient variant. J Virol. 2001;76:7481–8.

    Google Scholar 

  276. Nishino R, Ikeda K, Hayakawa T, Takahashi T, Suzuki T, Sato M. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1. Bioorg Med Chem. 2011;19:2418–27.

    PubMed  CAS  Google Scholar 

  277. Porotto M, Rockx B, Yokoyama C, et al. Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog. 2010;6(10):e1001168. doi:10.1371/journal.ppat.1001168.

    PubMed  PubMed Central  Google Scholar 

  278. Porotto M, Yokoyama C, Palermo LM, et al. Viral entry inhibitors targeted to the membrane site of action. J Virol. 2010;84:6760–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  279. Pessi A, Langella A, Capitò C, Ghezzi S, Vicenzi E, Poli G, Ketas T, Mathieu C, Cortese R, Horvat B, Mosconag A, Porotto M. A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity. PLoS One. 2012;7(5):e36833.

    PubMed  CAS  PubMed Central  Google Scholar 

  280. Farzan SF, Palermo LM, Yokoyama CC, et al. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery. J Biol Chem. 2011;286:37945–54.

    PubMed  CAS  PubMed Central  Google Scholar 

Suggested Reading

  • Glezen WP, GReenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2001;283:499–505.

    Google Scholar 

  • Hall CB. Respiratory syncytial virus and parainfluenza viruses. N Engl J Med. 2001;344:1917–28.

    PubMed  CAS  Google Scholar 

  • Moscona A. Entry of para influenza virus into cells as a target for internipting childhood resprratory disease. J Clin Ivest. 2005;115:1688–98.

    Google Scholar 

  • Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyarantanakarnit J, Karron RA, Collins PL. Progress in the development of human parainfluenza virus vaccines. Expert Rev Respir Med. 2011;5(4):515–26.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

The authors would like to acknowledge and thank Dr. W.P. Glezen for his contributions to previous versions of this chapter.

Author information

Authors and Affiliations

  1. Department of Pediatric Infectious Diseases, Seattle Children’s Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA

    Janet A. Englund MD

  2. Departments of Pediatrics and of Microbiology and Immunology, Weill Cornell Medical Centers, 505 East 70th Street, New York, NY, 10021, USA

    Anne Moscona MD

Authors
  1. Janet A. Englund MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Moscona MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Janet A. Englund MD or Anne Moscona MD .

Editor information

Editors and Affiliations

  1. Department of Epidemiology, University of Alabama, Birmingham School of Public Health, Birmingham, Alabama, USA

    Richard A. Kaslow

  2. Departmant of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Lawrence R. Stanberry

  3. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA

    James W. Le Duc

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Englund, J.A., Moscona, A. (2014). Paramyxoviruses: Parainfluenza Viruses. In: Kaslow, R., Stanberry, L., Le Duc, J. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7448-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7448-8_25

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7447-1

  • Online ISBN: 978-1-4899-7448-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation